Trending Articles

article thumbnail

The end-of-life doula: Making smooth the paths of people on the journey to death

STAT

For the Rev. Beth Stotts, death is a natural part of her ministry. A major aspect of her job is guiding her congregants through their most vulnerable moments from birth throughout life. The struggles she has seen in her community led her to seek more training to help people face death, and in 2022 she added another credential to her spiritual one: end-of-life doula.

273
273
article thumbnail

NHS England to be scrapped with funding 'reinvested into frontline services'

The Pharmacist

NHS England (NHSE) will be scrapped and brought back into the Department of Health and Social Care (DHSC) 'to put an end to the duplication resulting from two organisations doing the same job', the government has said today. Prime Minister Sir Kier Starmer set out major reforms today, which will include the dissolution of NHSE […] The post NHS England to be scrapped with funding 'reinvested into frontline services' appeared first on The Pharmacist.

116
116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

In the world of nutrition research, dairy is neither hero nor villain. It contains important nutrients like protein and calcium. Yet full-fat dairy also contains relatively high levels of saturated fat, which has been linked to increased levels of harmful LDL cholesterol and greater risk of stroke and heart disease. These complexities mean many health providers aim for nuance in how they talk about dairy, avoiding the full-throated endorsements they might give to leafy greens or legumes while di

article thumbnail

What’s driving pharma’s layoffs in 2025

PharmaVoice

Familiar foes in the industry have claimed a slew of jobs in recent months.

285
285
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Five Things For Pharmacists To Know About Measles in 2025

ID Stewardship

In this article a clinical infectious diseases pharmacist reviews five things for pharmacists to know about measles in 2025. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP – – POST UNDER CONSTRUCTION – – Article posted 8 March 2025 This week on Tuesday night a few text messages came through on WhatsApp chats about how there was a measles case from a high school student here in the Miami area.

More Trending

article thumbnail

Opinion: How physicians should talk to parents of unvaccinated children who have contracted measles

STAT

The ongoing measles outbreak in west Texas and a neighboring county in New Mexico has grown to more than 200 cases, concentrated in unvaccinated children. Twenty-three people have required hospitalization, and, tragically, a previously healthy, unvaccinated 6-year-old has died of the disease. An adult with measles in neighboring Lea County, New Mexico, has also died.

Vaccines 282
article thumbnail

Pharmacy First IT funding 'not well spent', says pharmacist MP

The Pharmacist

Money to develop IT systems to support the roll-out of Pharmacy First was 'not well spent', pharmacist and MP Sadik Al-Hassan has suggested. The Labour MP for North Somerset was speaking at a roundtable focusing on community pharmacy technology in parliament yesterday when he was asked by The Pharmacist for his views on the IT […] The post Pharmacy First IT funding 'not well spent', says pharmacist MP appeared first on The Pharmacist.

article thumbnail

As tariffs loom over pharma manufacturing, a reshoring effort is underway — but not without challenges

PharmaVoice

Experts say cost and other barriers present challenges to returning to U.S. shores.

238
238
article thumbnail

Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change

PhRMA

Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.

73
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

IA-2A positivity could help develop effective intervention strategies in type 1 diabetes progression: GlobalData

Express Pharma

A recent study published in Springer Medizin has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant biomarker for disease progression in individuals at risk of type 1 diabetes (T1D). The findings are particularly relevant as the T1D market undergoes a transformation driven by advancements in predictive diagnostics and disease-modifying therapies.

article thumbnail

NICE approves daily pill for endometriosis where other treatments have failed

The Pharmacist

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected. It is estimated around 1,000 patients a year will be able to access the treatment called relugolixestradiolnorethisterone (also known as relugolix combination therapy or Ryeqo). The turnaround from NICE came after the company provided new evidence on […] The post NICE approves daily pill for endometriosis where other treatments have failed appeared first on The Pharmacist.

79
article thumbnail

Lawmakers tease out pharma’s influence over RFK Jr. through probe into Mar-a-Lago meetings

PharmaVoice

HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.

217
217
article thumbnail

Merck opens $1B vaccine plant in North Carolina

BioPharma Dive

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S.

Vaccines 142
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Tenthpin Management Consultants launches AI labs in Hyderabad to drive life sciences Innovation

Express Pharma

Switzerland-based Tenthpin Management Consultants has announced the launch of Tenthpin AI Labs (TAIL) in Hyderabad, creating a Global Centre of Excellence for AI-driven transformation in the Life Sciences sector. TAIL aims to help pharmaceutical, MedTech, biotech, and research organisations differentiate between AI hype and real value. By leveraging India’s technology talent and Hyderabads position as a life sciences hub, Tenthpin seeks to accelerate AI adoption across the drug life cycle,

article thumbnail

Study reveals how often medical device makers report safety incidents late to FDA

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. In a new study in the BMJ , researchers analyzed the Food and Drug Administration database where manufactures report adverse events and found that a huge number of reports come in late.

264
264
article thumbnail

Sector hopes end of NHSE will mean more funding for community pharmacy

The Pharmacist

Community pharmacy leaders have expressed hope that the government's decision to abolish NHS England (NHSE) will mean more funding can be redirected to community pharmacy. Meanwhile, the sector's negotiator has pledged to work with 'whatever new structures and teams' are in place, while continuing to be 'fully focused' on current funding negotiations.

article thumbnail

The first new type of drug for Tourette syndrome in over 50 years is close to the FDA’s doorstep

PharmaVoice

Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.

165
165
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Strategies For A Pharma Ad Ban on TV

Pharma Marketing Network

Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.

article thumbnail

Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis

Express Pharma

Biocon Biologics announced the successful results of a pivotal Phase 3, randomised, double-blind, parallel group, multicenter study comparing Yesintek (Biocon Biologics biosimilar to Ustekinumab, called YESINTEK) with reference product Stelara (Ustekinumab) in adult patients with moderate to severe chronic plaque psoriasis (PsO). The data are being presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.

article thumbnail

STAT+: A U.K. trade group is due to lift its suspension of Novo Nordisk, but critics cite a lack of transparency

STAT

A U.K. industry trade group is due to lift a rare two-year suspension of Novo Nordisk over “serious breaches” promoting an obesity drug, but some academics are raising questions about the extent to which the public will know if the company has substantively changed its business practices. The two-year suspension was issued on March 16, 2023, by the Association of British Pharmaceutical Industry after receiving a complaint alleging the company sponsored courses on weight management

227
227
article thumbnail

Fact Sheet: the IRA’s “Pill Penalty”

Safe Biologics

Click below to read ASBM member WeWorkForHealth’s Fact Sheet on the effects of the IRA’s “Pill Penalty”, also known as the “Small-Molecule Penalty”, which disincentivizes R&D on chemically-derived medicines used to treat many serious conditions like cancer and heart disease: Click below to view

130
130
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Takeda’s $770M deal deepens Big Pharma’s omics push

PharmaVoice

The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.

130
130
article thumbnail

PPC Campaign Optimization for Pharma: Boosting ROI

Pharma Marketing Network

Introduction Pharmaceutical companies are investing heavily in digital advertising , and PPC campaign optimization is key to maximizing ROI while staying compliant. With strict regulations, increasing competition, and evolving ad platform policies, running a successful PPC campaign in pharma isnt as straightforward as in other industries. So, how can pharma brands ensure their Google Ads, LinkedIn campaigns, and paid social media ads are effective?

HIPAA 59
article thumbnail

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate tablets

Express Pharma

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Methenamine Hippurate Tablets USP, 1 gram. The approved product is a generic equivalent of Hiprex Tablets, 1 gram, in the United States. Methenamine Hippurate tablets are indicated for the prophylactic or suppressive treatment of frequently recurring urinary tract infections where long-term therapy is required.

66
article thumbnail

Opinion: HIV self-testing is easy, effective — and underutilized

STAT

In May 2024, the Massachusetts Department of Public Health released a troubling report on a cluster of HIV infections, with more than 200 new cases since 2018 attributable to injection drug use in the Boston region. These findings have national implications: Similar HIV outbreaks have been described nationwide during the overdose crisis, including in West Virginia , Indiana , and Ohio.

213
213
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

NICE recommends innovative endometriosis pill

European Pharmaceutical Review

NICE has recommended the first daily oral pill on the NHS to treat endometriosis. The new final draft guidance from NICE follows its earlier negative recommendation of relugolix estradiolnorethisterone (Ryeqo) relugolix combination therapy for this indication. The treatment offers key benefits including its administration by patients at home. “Instead of travelling to clinics for injections, there is now a daily tablet that can be taken at home,” stated Helen Knight , Director of Med

52
article thumbnail

Pricing transparency is in the spotlight — and that could be good news for drugmakers

PharmaVoice

An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can efforts to bring transparency into that system now pan out?

130
130
article thumbnail

Paid Social Media Campaigns for Pharma: Maximizing Engagement & Compliance

Pharma Marketing Network

Introduction Social media advertising has become an essential part of pharmaceutical marketing, offering direct access to healthcare professionals (HCPs), patients, and caregivers. However, paid social media campaigns in the pharmaceutical industry come with unique challenges, from strict regulatory guidelines to platform restrictions and audience targeting complexities.